Recognizing the rise of fatty liver disease, we’ve made it our mission to make liver health a new vital sign.

Our novel, portable, handheld solution assesses liver attenuation with ultrasound, and liver stiffness with technology similar to that of MRI elastography, the current non-invasive gold standard. VelacurTM aids in the clinical management of patients with liver disease, with measurements you can count on.

Founded in 2017, Sonic Incytes Medical Corp. is a medical device company headquartered in Vancouver, Canada.